Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Lupin Pharmaceuticals Inc.: Oseltamivir Phosphate for Oral Suspension Recalled for Impurity Concerns

Agency Publication Date: February 3, 2021
Share:
Sign in to monitor this recall

Summary

Lupin Pharmaceuticals Inc. has voluntarily recalled 46,479 bottles of Oseltamivir Phosphate for Oral Suspension (6 mg/mL). This prescription medication, commonly used to treat the flu, was found to have an impurity level that exceeded safety specifications during stability testing. Consumers should contact their healthcare provider or pharmacist regarding this recall and for guidance on their treatment.

Risk

The product failed long-term stability testing due to an out-of-specification result for 'Impurity C.' This means the drug may degrade faster than expected or contain unintended chemical byproducts, which could potentially impact the effectiveness or safety of the medication over time.

What You Should Do

  1. Check your medication bottle to see if you have Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, in the 60 mL usable volume size.
  2. Verify the identifying numbers on the label: look for NDC 68180-678-01 and specifically check for Lot # A906423 with an expiration date of November 2021 (exp. date Nov 2021).
  3. If your medication matches the affected lot, contact your healthcare provider or pharmacist immediately for guidance and to discuss alternative treatment options.
  4. Return any unused portion of the recalled medication to your pharmacy to receive a refund.
  5. Contact Lupin Pharmaceuticals Inc. at their Baltimore office or through their customer service channels if you have specific questions about the product return process.
  6. For additional questions or to report a problem, call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Oseltamivir Phosphate for Oral Suspension, 6 mg/mL (60 mL)
Model:
NDC: 68180-678-01
Recall #: D-0247-2021
Lot Numbers:
A906423 (Exp Nov 2021)
Date Ranges: November 2021

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 87195
Status: Resolved
Manufacturer: Lupin Pharmaceuticals Inc.
Sold By: pharmacies
Manufactured In: United States, India
Units Affected: 46,479 bottles
Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.